We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. LAS VEGAS — In a comparison of two vascular closure ...
For large-bore arterial access site closure after transfemoral transcatheter aortic valve replacement (TAVR), use of the Manta plug-based vascular closure device resulted in significantly more ...
Use of the Perclose ProGlide suture-mediated closure strategy to achieve vascular access-site hemostasis after transfemoral TAVR results in fewer major vascular complications than does deployment of ...
LAS VEGAS (MAY 21, 2019) - Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of ...
The plug-based Manta (Teleflex) device was associated with significantly more vascular complications than the suture-based ProGlide (Abbott Vascular) device following transfemoral transcatheter aortic ...
Use of a large-bore, plug-based vascular closure device (Manta; Teleflex) following transfemoral TAVI is associated with a higher risk of vascular complications when compared with an older ...
Abbott Park, IL - Abbott Laboratories announced the launch of the next-generation Perclose ® suture-mediated vessel closure system, Perclose ProGlide TM, featuring a polypropylene monofilament suture.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results